Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-07-10 2:17 pm Purchase | 13G | Black Diamond Therapeutics Inc. BDTX | T. Rowe Price Investment Management Inc. | 10,659,730 18.9% | 3,983,974![]() (+59.68%) | View |
2024-05-13 7:09 pm Purchase | 13D | Black Diamond Therapeutics Inc. BDTX | New Enterprise Associates 16 L.P. | 4,546,947 8.1% | 1,098,190![]() (+31.84%) | View |
2024-05-09 8:48 pm Purchase | 13D | Black Diamond Therapeutics Inc. BDTX | RA CAPITAL MANAGEMENT L.P. | 2,788,028 4.95% | 198,124![]() (+7.65%) | View |
2024-03-11 1:14 pm Purchase | 13G | Black Diamond Therapeutics Inc. BDTX | T. Rowe Price Investment Management Inc. | 6,675,756 12.9% | 2,747,877![]() (+69.96%) | View |
2024-02-14 10:04 am Purchase | 13G | Black Diamond Therapeutics Inc. BDTX | T. Rowe Price Investment Management Inc. | 3,927,879 7.6% | 3,927,879![]() (New Position) | View |
2024-02-13 06:05 am Purchase | 13G | Black Diamond Therapeutics Inc. BDTX | BB BIOTECH AG | 8,517,839 16.5% | 3,140,000![]() (+58.39%) | View |
2023-11-09 5:24 pm Unchanged | 13D | Black Diamond Therapeutics Inc. BDTX | Versant Venture Capital VI L.P. | 4,328,883 8.4% | 0 (Unchanged) | View |
2023-02-14 4:14 pm Purchase | 13G | Black Diamond Therapeutics Inc. BDTX | BB BIOTECH AG | 5,377,839 14.8% | 1,389,437![]() (+34.84%) | View |
2022-07-08 4:57 pm Sale | 13G | Black Diamond Therapeutics Inc. BDTX | BlackRock Inc. BLK | 1,272,112 3.5% | -976,355![]() (-43.42%) | View |
2022-04-14 12:01 pm Purchase | 13G | Black Diamond Therapeutics Inc. BDTX | BB BIOTECH AG | 3,988,402 11% | 548,402![]() (+15.94%) | View |
2022-02-11 4:57 pm Purchase | 13G | Black Diamond Therapeutics Inc. BDTX | BB BIOTECH AG | 3,440,000 9.5% | 1,540,000![]() (+81.05%) | View |
2022-02-09 3:33 pm Sale | 13G | Black Diamond Therapeutics Inc. BDTX | VANGUARD GROUP INC | 1,014,791 2.8% | -831,171![]() (-45.03%) | View |
2022-02-04 4:12 pm Purchase | 13G | Black Diamond Therapeutics Inc. BDTX | BlackRock Inc. BLK | 2,248,467 6.2% | 2,248,467![]() (New Position) | View |
2021-02-11 4:58 pm Purchase | 13G | Black Diamond Therapeutics Inc. BDTX | BB BIOTECH AG | 1,900,000 5.3% | 1,900,000![]() (New Position) | View |
2021-02-10 10:39 am Purchase | 13G | Black Diamond Therapeutics Inc. BDTX | VANGUARD GROUP INC | 1,845,962 5.13% | 1,845,962![]() (New Position) | View |
2020-12-03 4:47 pm Sale | 13D | Black Diamond Therapeutics Inc. BDTX | Versant Venture Capital VI L.P. | 4,328,883 12% | -1,031,634![]() (-19.25%) | View |
2020-11-20 5:32 pm Sale | 13D | Black Diamond Therapeutics Inc. BDTX | Versant Venture Capital VI L.P. | 5,360,517 14.9% | -980,734![]() (-15.47%) | View |
2020-09-25 4:37 pm Sale | 13D | Black Diamond Therapeutics Inc. BDTX | Versant Venture Capital VI L.P. | 6,341,251 17.7% | -457,424![]() (-6.73%) | View |
2020-08-21 4:19 pm Sale | 13D | Black Diamond Therapeutics Inc. BDTX | Versant Venture Capital VI L.P. | 6,798,675 18.9% | -669,608![]() (-8.97%) | View |
2020-02-13 5:23 pm Purchase | 13D | Black Diamond Therapeutics Inc. BDTX | Versant Venture Capital VI L.P. | 7,468,283 20.8% | 7,468,283![]() (New Position) | View |